基于多的局部输送纳米纤维系统的全面审查
Anshu Singh1, Zeeshan Fatima1, Dipti Srivastava2
1Department of Pharmacy, Amity Institute of Pharmacy, Lucknow, Amity University Uttar Pradesh Lucknow, Noida, 201313, India.
Current drug delivery
|January 27, 2024
概括
植物中的天然化合物聚醇在通过纳米纤维递送时显示出对皮肤疾病的前景. 这些系统增强了多的特性和局部应用的有效性,可能取代其他疗法.
科学领域:
- 药理学 药理学是指药理学的学科.
- 皮肤病学 皮肤病学
- 纳米技术 纳米技术
背景情况:
- 多是植物代谢物,具有抗氧化,抗炎和抗菌性质.
- 它们在丰富多彩的水果和蔬菜中的自然丰富性使得它们非常适合针对皮肤疾病.
- 这些化合物具有治疗各种皮肤病的巨大潜力.
研究的目的:
- 探索多荷载纳米纤维用于治疗皮肤疾病.
- 审查不同囊泡系统的疗效封装多的皮肤病学应用.
- 识别基于多的皮肤药物输送系统未来研究的机会.
主要方法:
- 在Web of Science,PubMed,Scopus和谷歌学者中进行文献搜索.
- 结果根据标题,摘要和全文可用性进行过.
- 对用于皮肤的多纳米纤维配方现有研究进行系统审查.
主要成果:
- 已经开发出各种纳米纤维 (脂质体,阴质体,乙质体,转移体) 结合了多.
- 这些纳米纤维系统表现出改善的物理化学特性,用于皮肤输送.
- 在含聚醇的纳米微粒中观察到增强的药理作用.
结论:
- 基于多的纳米体配方对局部药物输送是有效的.
- 这些先进的系统可能会减少对不太有效的传统皮肤疗法的依赖.
- 纳米片为开发用于皮肤疾病的新疗法提供了一个有前途的平台.
相关概念视频
Drug Delivery: Overview
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the gastrointestinal...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the gastrointestinal...
Drug Delivery Systems: Different Types
Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...
Modified-Release Drug Delivery Systems: Overview
Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Oral Drug Delivery Systems: Introduction
Oral drug delivery is the most common route of administration due to its convenience, cost-effectiveness, and high patient compliance. It enables precise formulation to ensure proper drug dosage and bioavailability. The development of oral dosage forms considers drug properties such as solubility, stability, and absorption to optimize therapeutic efficacy.Tablets, capsules, liquids, and chewable formulations enhance drug stability, mask undesirable tastes, and improve patient experience.


